Non-invasive cervical cancer prototypes show promise
This article was originally published in Clinica
Executive Summary
Prototypes of a non-invasive cervical cancer detection device have shown promising early results in US feasibility studies. The devices, developed by Welch Allyn and SpectRx, produced results that correlated with histology in the identification of high- and low-grade cervical lesions, some of which had been wrongly classified by traditional Pap smears, the US companies said.